Ahmad M - Search Results

1

Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.

Saif JM, Vadakekolathu J, Rane SS, McDonald D, Ahmad M, Mathieu M, Pockley AG, Durrant L, Metheringham R, Rees RC, McArdle SE. Saif JM, et al. Among authors: ahmad m. Eur J Immunol. 2014 Apr;44(4):994-1004. doi: 10.1002/eji.201343863. Epub 2014 Mar 7. Eur J Immunol. 2014. PMID: 24338683 Free article.

2

The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.

Mathieu MG, Miles AK, Ahmad M, Buczek ME, Pockley AG, Rees RC, Regad T. Mathieu MG, et al. Among authors: ahmad m. Cell Death Dis. 2014 Feb 13;5(2):e1061. doi: 10.1038/cddis.2014.29. Cell Death Dis. 2014. PMID: 24525737 Free PMC article.

3

Trafficking of tumor peptide-specific cytotoxic T lymphocytes into the tumor microcirculation.

Ali S, Ahmad M, Lynam J, Rees RC, Brown N. Ali S, et al. Among authors: ahmad m. Int J Cancer. 2004 Jun 10;110(2):239-44. doi: 10.1002/ijc.20113. Int J Cancer. 2004. PMID: 15069688 Free article.

4

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

Ahmad M, Rees RC, Ali SA. Ahmad M, et al. Cancer Immunol Immunother. 2004 Oct;53(10):844-54. doi: 10.1007/s00262-004-0540-x. Epub 2004 Jun 10. Cancer Immunol Immunother. 2004. PMID: 15197495 Free PMC article. Review.

5

Anti-tumour therapeutic efficacy of OX40L in murine tumour model.

Ali SA, Ahmad M, Lynam J, McLean CS, Entwisle C, Loudon P, Choolun E, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: ahmad m. Vaccine. 2004 Sep 9;22(27-28):3585-94. doi: 10.1016/j.vaccine.2004.03.041. Vaccine. 2004. PMID: 15315837 Free article.

6

Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF.

Ahmad M, Rees RC, McArdle SE, Li G, Mian S, Entwisle C, Loudon P, Ali SA. Ahmad M, et al. Int J Cancer. 2005 Jul 20;115(6):951-9. doi: 10.1002/ijc.20976. Int J Cancer. 2005. PMID: 15723299 Free article.

7

Immunity to tumour antigens.

Li G, Ali SA, McArdle SE, Mian S, Ahmad M, Miles A, Rees RC. Li G, et al. Among authors: ahmad m. Curr Pharm Des. 2005;11(27):3501-9. doi: 10.2174/138161205774414583. Curr Pharm Des. 2005. PMID: 16248804 Review.

8

The identification of human tumour antigens: Current status and future developments.

Miles AK, Matharoo-Ball B, Li G, Ahmad M, Rees RC. Miles AK, et al. Among authors: ahmad m. Cancer Immunol Immunother. 2006 Aug;55(8):996-1003. doi: 10.1007/s00262-005-0115-5. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408215 Free PMC article. Review.

9

Tumour-associated antigens: considerations for their use in tumour immunotherapy.

Linley AJ, Ahmad M, Rees RC. Linley AJ, et al. Among authors: ahmad m. Int J Hematol. 2011 Mar;93(3):263-273. doi: 10.1007/s12185-011-0783-1. Epub 2011 Mar 1. Int J Hematol. 2011. PMID: 21360066 Review.

10

Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.

Rees RC, McArdle S, Mian S, Li G, Ahmad M, Parkinson R, Ali SA. Rees RC, et al. Among authors: ahmad m. Curr Opin Mol Ther. 2002 Feb;4(1):49-53. Curr Opin Mol Ther. 2002. PMID: 11883695 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,444 results

Search Page